SHORT CONSENSUS REPEAT-3 DOMAIN OF RECOMBINANT DECAY-ACCELERATING FACTOR IS RECOGNIZED BY ESCHERICHIA-COLI RECOMBINANT DR ADHESIN IN A MODEL OF A CELL-CELL INTERACTION

被引:133
作者
NOWICKI, B
HART, A
COYNE, KE
LUBLIN, DM
NOWICKI, S
机构
[1] UNIV TEXAS,MED BRANCH,DEPT MICROBIOL,GALVESTON,TX 77550
[2] WASHINGTON UNIV,SCH MED,DEPT PATHOL,DIV LAB MED,ST LOUIS,MO 63110
[3] WASHINGTON UNIV,SCH MED,DEPT MED,ST LOUIS,MO 63110
关键词
D O I
10.1084/jem.178.6.2115
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
A bacterial pathogen that is important in both urinary tract and intestinal infections is Escherichia coli which expresses Dr or related adhesins. In this report, we present a model for testing cell-cell interaction, using both molecularly characterized laboratory cells that express recombinant molecules of human decay-accelerating factor (DAF), and recombinant bacterial Dr colonization factors. Dr adhesin ligand was identified as DAF (CD55), a membrane protein that protects autologous tissues from damage due to the complement system. Structure-function studies mapped the adhesin-binding site on the DAF molecule. A single-point substitution in the third short consensus repeat domain, Ser165 to Leu, corresponding tc the Dr(a) to Dr(b) allelic polymorphism, caused complete abolition of adhesin binding to DAF.
引用
收藏
页码:2115 / 2121
页数:7
相关论文
共 35 条
[1]   PREVENTION OF COLONIZATION OF THE URINARY-TRACT OF MICE WITH ESCHERICHIA-COLI BY BLOCKING OF BACTERIAL ADHERENCE WITH METHYL ALPHA-D-MANNOPYRANOSIDE [J].
ARONSON, M ;
MEDALIA, O ;
SCHORI, L ;
MIRELMAN, D ;
SHARON, N ;
OFEK, I .
JOURNAL OF INFECTIOUS DISEASES, 1979, 139 (03) :329-332
[2]   MOLECULAR CHARACTERIZATION OF A FIMBRIAL ADHESIN, F1845, MEDIATING DIFFUSE ADHERENCE OF DIARRHEA-ASSOCIATED ESCHERICHIA-COLI TO HEP-2 CELLS [J].
BILGE, SS ;
CLAUSEN, CR ;
LAU, W ;
MOSELEY, SL .
JOURNAL OF BACTERIOLOGY, 1989, 171 (08) :4281-4289
[3]   CHRONIC DIARRHEA IN INFANTS CAUSED BY ADHERENT ENTEROPATHOGENIC ESCHERICHIA-COLI [J].
CLAUSEN, CR ;
CHRISTIE, DL .
JOURNAL OF PEDIATRICS, 1982, 100 (03) :358-361
[4]  
COYNE KE, 1992, J IMMUNOL, V149, P2906
[5]   A POSSIBLE NULL PHENOTYPE IN THE CROMER BLOOD-GROUP COMPLEX [J].
DANIELS, GL ;
TOHYAMA, H ;
UCHIKAWA, M .
TRANSFUSION, 1982, 22 (05) :362-363
[6]  
DUGUID JP, 1980, RECEPTORS RECOGNIT B, P185
[7]   LIPOFECTION - A HIGHLY EFFICIENT, LIPID-MEDIATED DNA-TRANSFECTION PROCEDURE [J].
FELGNER, PL ;
GADEK, TR ;
HOLM, M ;
ROMAN, R ;
CHAN, HW ;
WENZ, M ;
NORTHROP, JP ;
RINGOLD, GM ;
DANIELSEN, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (21) :7413-7417
[8]   EXPRESSION OF MEMBRANE INTERLEUKIN-1 BY FIBROBLASTS TRANSFECTED WITH MURINE PRO-INTERLEUKIN-1-ALPHA CDNA [J].
FUHLBRIGGE, RC ;
FINE, SM ;
UNANUE, ER ;
CHAPLIN, DD .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (15) :5649-5653
[9]   INHIBITION OF COMPLEMENT BY A SUBSTANCE ISOLATED FROM HUMAN ERYTHROCYTES .I. EXTRACTION FROM HUMAN ERYTHROCYTE STROMATA [J].
HOFFMANN, EM .
IMMUNOCHEMISTRY, 1969, 6 (03) :391-&
[10]   ANTIPHAGOCYTIC ACTIVITY OF STREPTOCOCCAL-M PROTEIN - SELECTIVE BINDING OF COMPLEMENT CONTROL PROTEIN FACTOR-H [J].
HORSTMANN, RD ;
SIEVERTSEN, HJ ;
KNOBLOCH, J ;
FISCHETTI, VA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (05) :1657-1661